Diagenode

Participants aim to use predictive modeling to better understand epigenetic mechanisms, while encouraging the development of new technologies and therapies.

Diagenode said the deal will bolster its suite of epigenomics services and platforms, as well as enhance its epigenetic biomarker discovery efforts.

LGC will supply DNA fragmentation instruments for clinical and agricultural biotechnology customers.

The Belgian company recently received €3.6 million to develop the signature into a clinical test within the next three years.

NEW YORK (GenomeWeb) — Becton Dickinson's BD Diagnostics division announced this week the launch of the Total Nucleic Acid suite, a kit of reagents to enable DNA- and RNA-based assay development on the automated BD Max platform.

The US Food and Drug Administration has approved BioFire Diagnostics' FilmArray Blood Culture Identification Panel. BioFire said that the 27-target panel is the most comprehensive blood culture test to be approved by the FDA.

Luminex said this week that it has received clearance from the US Food and Drug Administration for its MagPix instrument and xTAG Gastrointestinal Pathogen Panel, or GPP.

BD Diagnostics, a division of Becton Dickinson, and Belgium's Diagenode this week announced the European launch of Diagenode's influenza A and B assay for use on the BD Max molecular testing system.

NEW YORK (GenomeWeb News) – Rubicon Genomics will integrate its ThruPlex technology into Diagenode's epigenetics platforms under a partnership announced today.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.